Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area
Country
Application Due Date
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
Release Date:
Review Process: Pfizer Internal
Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date
2021 Ulcerative Colitis Competitive Grant Program
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology USA
Adoption of Biosimilars in Oncology
Release Date:
Review Process: Pfizer Internal
Quality Improvement Oncology Canada
2021 Global Hemophilia ASPIRE
Release Date:
Review Process: Expert Review Panel
Research Rare Disease All
Inflammatory and Immune-Mediated Dermatologic Disorders
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology USA
Advances in Atopic Dermatitis & Alopecia Areata for Community Pharmacists & Managed Care Health Care Professionals
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Understanding Residual Cardiovascular Risk Related to Triglyceride-Rich Remnant Lipoproteins
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine All
Call for Independent Medical Education Grant Applications Oncology – Prostate Cancer
Release Date:
Partner: Astellas
Review Process: Pfizer Internal
Education Oncology USA
I&I REALE 2021 RhEumatoid Arthritis Italian ReaL World Experience
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology Italy
2021 Rheumatology Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology USA
2021 Inflammatory Bowel Disease (IBD) Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology USA
Inflammatory and Immune-Mediated Dermatologic Disorders (Global excluding U.S.)
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology All
2021 Fellowship for Inflammatory Dermatological Diseases
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology USA